Announcements Trials
Browse Landscape Eligibility

Clinical Trials

3 trials
RecentStart dateEnrollment
Sex × Clear all

Phase

Phase NA 3

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1

Conditions

Prostatic Neoplasms 1Gynecologic Cancer 1Communication 1

Interventions

Cyclophosphamide 2682Cisplatin 2665Carboplatin 2463Radiotherapy 2373Paclitaxel 2265Gemcitabine 2128pembrolizumab 1994Docetaxel 1884Bevacizumab 1821Fluorouracil 1548Capecitabine 1532Oxaliplatin 1440Dexamethasone 1330Nivolumab 1300Doxorubicin 1261Rituximab 1251Magnetic Resonance Spectroscopy 1150Etoposide 1127Irinotecan 1038Leucovorin 1020Drug Therapy 999Cytarabine 964Pemetrexed 891fludarabine 890Specimen Handling 822Vincristine 794Lenalidomide 791Prednisone 787Cetuximab 785Trastuzumab 785

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements
NCT05359952 2024-09-25

Women's Health Communication Study

Fox Chase Cancer Center

Phase NA Completed
32 enrolled 29 charts
Gynecologic

Gynecologic Cancer

NCT03624972 2021-03-16

Addressing Sexual Concerns in Breast Cancer: Patient Intervention Study

Fox Chase Cancer Center

Phase NA Completed
153 enrolled 53 charts

Communication

NCT02103088 2021-02-04

PROCAN

Danish Cancer Society

Phase NA Completed
72 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡